Disentangling the MYC web
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
That MYC is causally associated with cancer has been apparent for decades. As a retroviral transforming gene or as the target of chromosomal translocations, rearrangements, amplification, mutations, and viral insertions, disturbance of MYC regulation and/or function is one of the most common molecular lesions contributing to multistep carcinogenesis (1–5). Disordered MYC expression alters cell proliferation, cell growth, differentiation, and metabolism. How MYC provokes this panoply of cellular pathology has been debated for years. Whether MYC acts directly on a small number of downstream effectors that elicit many secondary changes or whether MYC itself directly operates on all of these processes has been controversial. The works of Menssen and Hermeking (6) in this issue of PNAS and other recent studies (6–11) point to a complex web of direct MYC targets regulating metabolic flux and information streams through normal and transformed cells. Their work indicates the need for new tools to understand how multiple signals and processes are superimposed and integrated to determine the fate of a cell.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
McMahon, S. B., Wood, M. A., & Cole, M. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.556-562.2000 · Cited by 494
Cited by
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188
Transcriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,131
HIF-1α induces cell cycle arrest by functionally counteracting Myc
Koshiji, M., Kageyama, Y., Pete, E. A., Horikawa, I., Barrett, J. C., & Huang, L. E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600196 · Cited by 652
A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells
Li, Z., Van Calcar, S., Qu, C., Cavenee, W. K., Zhang, M. Q., & Ren, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332764100 · Cited by 524
Lymphoid Malignancies: the dark side of B-cell differentiation
Shaffer, A. L., Rosenwald, A., & Staudt, L. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri953 · Cited by 419
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells
Venturini, L., Battmer, K., Castoldi, M., Schultheis, B., Hochhaus, A., Muckenthaler, M. U., Ganser, A., Eder, M., & Scherr, M. (2007) · Blood · doi:10.1182/blood-2006-09-045104 · Cited by 353
Roles of the NF- B Pathway in Lymphocyte Development and Function
Gerondakis, S., & Siebenlist, U. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000182 · Cited by 320
Wu, S., Cetinkaya, C., Munoz-Alonso, M. J., von der Lehr, N., Bahram, F., Beuger, V., Eilers, M., Leon, J., & Larsson, L.-G. (2003) · Oncogene · doi:10.1038/sj.onc.1206145 · Cited by 317
Negative Regulation of the Mammalian UV Response by Myc through Association with Miz-1
Herold, S., Wanzel, M., Beuger, V., Frohme, C., Beul, D., Hillukkala, T., Syvaoja, J., Saluz, H.-P., Haenel, F., & Eilers, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00633-0 · Cited by 307
Circadian molecular clocks and cancer
Kelleher, F. C., Rao, A., & Maguire, A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.09.040 · Cited by 276
The Biology of Human Lymphoid Malignancies Revealed by Gene Expression Profiling
Staudt, L. M., & Dave, S. (2005) · Advances in Immunology · doi:10.1016/s0065-2776(05)87005-1 · Cited by 260
A library of gene expression signatures to illuminate normal and pathological lymphoid biology
Shaffer, A. L., Wright, G., Yang, L., Powell, J., Ngo, V., Lamy, L., Lam, L. T., Davis, R. E., & Staudt, L. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00373.x · Cited by 228
“Although c-myc is likely to play a role in cell cycle progression, much of its regulatory biology is geared to enhancing cell growth and metabolism (111).”
BackgroundTranscriptional repression by Myc
Wanzel, M., Herold, S., & Eilers, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00003-5 · Cited by 216
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
Zanet, J., Pibre, S., Jacquet, C., Ramirez, A., de Alborán, I. M., & Gandarillas, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02298 · Cited by 123
“Accordingly, Myc candidate targets include genes involved not only in cell cycle and apoptosis, but also in cell metabolism and protein and RNA biosynthesis (Levens, 2002; Gomez-Roman et al., 2003).”
Backgroundc-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver
Baena, E., Gandarillas, A., Vallespinós, M., Zanet, J., Bachs, O., Redondo, C., Fabregat, I., Martinez-A., C., & de Alborán, I. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409260102 · Cited by 104
Metadata
- Authors
- Levens, D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-04-30
- Volume
- 99
- Issue
- 9
- Pages
- 5757-5759
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2155224240
- Cited by
- 118
- References
- 1
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.